Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School

Last Updated: December 14, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Capravirine

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the development status for investigational drug Capravirine?

Capravirine is an investigational drug.

There have been 9 clinical trials for Capravirine. The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 1999.

The most common disease conditions in clinical trials are HIV Infections, Acquired Immunodeficiency Syndrome, and Communicable Diseases. The leading clinical trial sponsors are Agouron Pharmaceuticals, Pfizer, and National Institute of Allergy and Infectious Diseases (NIAID).

Recent Clinical Trials for Capravirine
Four-Drug Combination Treatment in Hiv-Infected Subjects Failing Therapy With Antiretroviral RegimensPfizerPhase 2
Capravirine (AG1549) in Combination With Viracept and Two NRTIs in HIV Infected Patients Who Failed an Initial NNRTI Containing RegimenPfizerPhase 2
Capravirine to Treat Children With HIV InfectionNational Cancer Institute (NCI)Phase 1

See all Capravirine clinical trials

Clinical Trial Summary for Capravirine

Top disease conditions for Capravirine
Top clinical trial sponsors for Capravirine

See all Capravirine clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.